Patents by Inventor Johannes Hampl

Johannes Hampl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 10087258
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: October 2, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20180237512
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: April 18, 2018
    Publication date: August 23, 2018
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JOHANNES HAMPL, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL
  • Modulators and methods of use
    Patent number: 9969798
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: May 15, 2018
    Assignee: AbbVie Stemcentrx LLP
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • Modulators and methods of use
    Patent number: 9765136
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: September 19, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • ANTI-CD324 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20170121416
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 4, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. STULL, Monette AUJAY, Orit FOORD, Alex BANKOVICH, Johannes HAMPL, Scott J. DYLLA, David LIU
  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 9534058
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: January 3, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20160264653
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: March 17, 2016
    Publication date: September 15, 2016
    Applicant: STEMCENTRX, INC.
    Inventors: JOHANNES HAMPL, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20160257745
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: March 17, 2016
    Publication date: September 8, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: JOHANNES HAMPL, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL
  • Modulators and methods of use
    Patent number: 9320812
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: April 26, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • ANTI-CD324 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20150337048
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: February 8, 2013
    Publication date: November 26, 2015
    Inventors: Robert A. STULL, Monette AUJAY, Orit FOORD, Alex BANKOVICH, Johannes HAMPL, Scott J. DYLLA, David LIU
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20140302034
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: December 7, 2011
    Publication date: October 9, 2014
    Applicant: Stem CentRx, Inc.
    Inventors: Alex Bankovich, Orit Foord, Johannes Hampl, Scott J. Dylla
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20140093495
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: December 7, 2011
    Publication date: April 3, 2014
    Applicant: Stem CentRx, Inc.
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • Novel Modulators and Methods of Use
    Publication number: 20130058947
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: February 8, 2012
    Publication date: March 7, 2013
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla